RPR121056-d3 is the deuterium labeled RPR121056. RPR121056 is a metabolite of Irinotecan ( HY-16562 ), which is generated by CYP3A4 . Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the study of colorectal cancer . Irinotecan also directly inhibits AChE .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Topoisomerase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.